Surmodics Price to Sales Ratio 2010-2025 | SRDX
Historical PS ratio values for Surmodics (SRDX) over the last 10 years. The current P/S ratio for Surmodics as of May 05, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Surmodics P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-05-05 | 26.97 | 3.15 | |
| 2025-03-31 | 30.53 | $8.56 | 3.57 |
| 2024-12-31 | 39.60 | $8.84 | 4.48 |
| 2024-09-30 | 38.78 | $8.91 | 4.35 |
| 2024-06-30 | 42.04 | $8.55 | 4.91 |
| 2024-03-31 | 29.34 | $10.14 | 2.89 |
| 2023-12-31 | 36.35 | $9.83 | 3.70 |
| 2023-09-30 | 32.09 | $9.44 | 3.40 |
| 2023-06-30 | 31.31 | $9.32 | 3.36 |
| 2023-03-31 | 22.78 | $7.37 | 3.09 |
| 2022-12-31 | 34.12 | $7.31 | 4.67 |
| 2022-09-30 | 30.40 | $7.19 | 4.23 |
| 2022-06-30 | 37.23 | $7.03 | 5.29 |
| 2022-03-31 | 45.33 | $6.97 | 6.50 |
| 2021-12-31 | 48.15 | $7.60 | 6.34 |
| 2021-09-30 | 55.60 | $7.57 | 7.34 |
| 2021-06-30 | 54.25 | $7.49 | 7.24 |
| 2021-03-31 | 56.07 | $7.72 | 7.27 |
| 2020-12-31 | 43.52 | $6.87 | 6.33 |
| 2020-09-30 | 38.91 | $6.88 | 5.65 |
| 2020-06-30 | 43.24 | $7.49 | 5.77 |
| 2020-03-31 | 33.32 | $7.31 | 4.56 |
| 2019-12-31 | 41.43 | $7.30 | 5.68 |
| 2019-09-30 | 45.74 | $7.26 | 6.30 |
| 2019-06-30 | 43.17 | $6.78 | 6.37 |
| 2019-03-31 | 43.48 | $6.69 | 6.50 |
| 2018-12-31 | 47.26 | $6.46 | 7.32 |
| 2018-09-30 | 74.65 | $6.15 | 12.13 |
| 2018-06-30 | 55.20 | $5.90 | 9.36 |
| 2018-03-31 | 38.05 | $5.54 | 6.86 |
| 2017-12-31 | 28.00 | $5.43 | 5.15 |
| 2017-09-30 | 31.00 | $5.45 | 5.69 |
| 2017-06-30 | 28.15 | $5.33 | 5.28 |
| 2017-03-31 | 24.05 | $5.50 | 4.37 |
| 2016-12-31 | 25.40 | $5.46 | 4.65 |
| 2016-09-30 | 30.09 | $5.40 | 5.58 |
| 2016-06-30 | 23.48 | $5.33 | 4.40 |
| 2016-03-31 | 18.41 | $5.03 | 3.66 |
| 2015-12-31 | 20.27 | $4.85 | 4.18 |
| 2015-09-30 | 21.84 | $4.65 | 4.69 |
| 2015-06-30 | 23.42 | $4.45 | 5.26 |
| 2015-03-31 | 26.03 | $4.31 | 6.04 |
| 2014-12-31 | 22.10 | $4.21 | 5.25 |
| 2014-09-30 | 18.16 | $4.14 | 4.39 |
| 2014-06-30 | 21.42 | $4.00 | 5.35 |
| 2014-03-31 | 22.60 | $3.92 | 5.77 |
| 2013-12-31 | 24.39 | $3.85 | 6.34 |
| 2013-09-30 | 23.78 | $3.79 | 6.27 |
| 2013-06-30 | 20.01 | $3.61 | 5.54 |
| 2013-03-31 | 27.25 | $3.44 | 7.93 |
| 2012-12-31 | 22.36 | $3.21 | 6.97 |
| 2012-09-30 | 20.22 | $2.96 | 6.84 |
| 2012-06-30 | 17.30 | $2.96 | 5.85 |
| 2012-03-31 | 15.37 | $2.91 | 5.28 |
| 2011-12-31 | 14.66 | $2.98 | 4.92 |
| 2011-09-30 | 9.10 | $3.02 | 3.01 |
| 2011-06-30 | 11.10 | $3.12 | 3.56 |
| 2011-03-31 | 12.50 | $3.45 | 3.62 |
| 2010-12-31 | 11.87 | $3.74 | 3.17 |
| 2010-09-30 | 11.92 | $4.02 | 2.96 |
| 2010-06-30 | 16.41 | $4.23 | 3.88 |
| 2010-03-31 | 20.94 | $4.20 | 4.99 |
| 2009-12-31 | 22.66 | $4.35 | 5.21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.395B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.085B | 27.79 |
| Boston Scientific (BSX) | United States | $155.238B | 38.86 |
| Stryker (SYK) | United States | $144.362B | 30.18 |
| EssilorLuxottica (ESLOY) | France | $132.860B | 0.00 |
| Medtronic (MDT) | Ireland | $108.824B | 15.89 |
| Lonza Group Ag (LZAGY) | Switzerland | $52.624B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.259B | 27.44 |
| ResMed (RMD) | United States | $35.183B | 26.43 |
| GE HealthCare Technologies (GEHC) | United States | $32.295B | 15.33 |
| Agilent Technologies (A) | United States | $30.971B | 20.46 |
| Terumo (TRUMY) | Japan | $29.019B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $24.053B | 17.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.255B | 12.80 |
| Insulet (PODD) | United States | $18.084B | 77.18 |
| Baxter (BAX) | United States | $15.752B | 11.77 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.535B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $7.970B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.447B | 18.31 |
| Bio-Rad Laboratories (BIO) | United States | $6.620B | 22.38 |
| Prestige Consumer Healthcare (PBH) | United States | $4.171B | 19.90 |
| Perrigo (PRGO) | Ireland | $3.497B | 10.01 |
| ICU Medical (ICUI) | United States | $3.486B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.208B | 15.10 |
| Envista Holdings (NVST) | United States | $2.880B | 23.93 |
| GN Store Nord (GNNDY) | Denmark | $2.068B | 17.13 |
| QuidelOrtho (QDEL) | United States | $1.964B | 16.45 |
| LeMaitre Vascular (LMAT) | United States | $1.778B | 39.75 |
| AtriCure (ATRC) | United States | $1.486B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.374B | 21.63 |
| Neogen (NEOG) | United States | $1.248B | 15.97 |
| Kestra Medical Technologies (KMTS) | United States | $1.220B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.200B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.184B | 11.40 |
| InMode (INMD) | Israel | $1.013B | 9.28 |
| Phibro Animal Health (PAHC) | United States | $0.789B | 12.10 |
| Evolus (EOLS) | United States | $0.779B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.637B | 0.00 |
| CeriBell (CBLL) | United States | $0.588B | 0.00 |
| Owens & Minor (OMI) | United States | $0.580B | 4.94 |
| Valneva SE (VALN) | France | $0.549B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.542B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.526B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.458B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.442B | 0.00 |
| Omeros (OMER) | United States | $0.418B | 0.00 |
| SNDL (SNDL) | Canada | $0.365B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 15.55 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.296B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.292B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.291B | 26.32 |
| Aurora Cannabis (ACB) | Canada | $0.272B | 48.40 |
| Sanuwave Health (SNWV) | United States | $0.264B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.60 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.233B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.231B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| Biote (BTMD) | United States | $0.190B | 4.35 |
| Utah Medical Products (UTMD) | United States | $0.173B | 13.93 |
| Brainsway (BWAY) | Israel | $0.170B | 53.06 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| Organigram Global (OGI) | Canada | $0.154B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.148B | 18.22 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.108B | 0.00 |
| Agape ATP (ATPC) | $0.099B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.70 |
| Jushi Holdings (JUSHF) | United States | $0.076B | 0.00 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| United Health Products (UEEC) | United States | $0.064B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Apyx Medical (APYX) | United States | $0.047B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.042B | 61.50 |
| United-Guardian (UG) | United States | $0.037B | 11.28 |
| Safety Shot (SHOT) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |